Biogenic membranes contain the enzymes that synthesize the cell's membrane lipids, of which the phospholipids are the most widespread throughout nature. Being synthesized at and inserted into the cytoplasmic leaflet of biogenic membranes, the phospholipids must migrate to the opposite leaflet to ensure balanced growth of the membrane. In this review, the current knowledge of transbilayer movement of phospholipids in biogenic membranes is summarized and the available data are compared to what is known about lipid translocation in other membranes. On the basis of this, a mechanism is proposed, in which phospholipid translocation in biogenic membranes is mediated via membrane-spanning segments of a subset of proteins, characterized by a small number of transmembrane helices. We speculate that proteins of this subset facilitate lipid translocation via the protein-lipid interface, because they display more dynamic behavior and engage in less stable protein-lipid interactions than larger membrane proteins.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/bi036200f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Understanding antimicrobial activity of biogenic selenium nanoparticles and selenium/chitosan nano-incorporates via studying their inhibition activity against key metabolic enzymes.
Int J Biol Macromol
January 2025
Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt.
Microbial metabolic enzymes play a crucial role in several biological processes that have a significant impact on growth and proliferation. Therefore, inhibiting specific key metabolic enzymes can be an applicable approach for developing antimicrobial agents that selectively target pathogens. In the current study, selenium nanoparticles (Se NPs) extracellularly biosynthesized by Nocardiopsis sp.
View Article and Find Full Text PDFMorphology remodelling and membrane channel formation in synthetic cells via reconfigurable DNA nanorafts.
Nat Mater
January 2025
2nd Physics Institute, University of Stuttgart, Stuttgart, Germany.
The shape of biological matter is central to cell function at different length scales and determines how cellular components recognize, interact and respond to one another. However, their shapes are often transient and hard to reprogramme. Here we construct a synthetic cell model composed of signal-responsive DNA nanorafts, biogenic pores and giant unilamellar vesicles (GUVs).
View Article and Find Full Text PDFTargeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012-2024).
Molecules
December 2024
Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan.
Monoamine oxidase B (MAO-B) is a key enzyme in the mitochondrial outer membrane, pivotal for the oxidative deamination of biogenic amines. Its overexpression has been implicated in the pathogenesis of several cancers, including glioblastoma and colorectal, lung, renal, and bladder cancers, primarily through the increased production of reactive oxygen species (ROS). Inhibition of MAO-B impedes cell proliferation, making it a potential therapeutic target.
View Article and Find Full Text PDFToward one-step As(III) removal in ultrafiltration with in situ BioMnO cake layer: Mechanism and feasibility insights.
Water Res
January 2025
School of Civil Engineering, Wuhan University, Wuhan, 430072, PR China. Electronic address:
Inorganic arsenic (As) is one of the most significant chemical contaminants in drinking water worldwide. Although membrane-based technologies are commonly used for As removal, they often encounter challenges including complex operation, high energy consumption, and the need for chemical addition. To address these challenges, we proposed a one-step ultrafiltration (UF) process empowered by in situ biogenic manganese oxides (BioMnO) cake layers without any additional chemicals, to treat source water contaminated with both As and manganese (Mn).
View Article and Find Full Text PDFTherapeutic Potential of Agmatine in Essential Tremor Through Regulation of Lingo-1 and Inflammatory Pathways.
Brain Behav
January 2025
Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Purpose: Essential tremor (ET) is a prevalent movement disorder, yet current therapeutic options remain limited. Emerging evidence implicates leucine-rich repeat and immunoglobulin-like domain-containing protein (Lingo-1) and neuroinflammation in the pathophysiology of ET. This study aimed to investigate whether agmatine, a biogenic amine neuromodulator attenuates tremors and modulates the expression of Lingo-1 and proinflammatory markers in a rodent model of ET.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!